Study offers way to predict onset of lung disease in children with cystic fibrosis
Cystic fibrosis (CF) shortens life by making the lungs prone to repeated bacterial infections and associated inflammation. UNC School of...
Cystic fibrosis drug Orkambi 'approved for use among 6-11 year olds'
The pharmaceutical firm making cystic fibrosis drug Orkambi says it has received EU approval to treat children. Manufacturer Vertex says...
Protein structure could unlock new treatments for cystic fibrosis
Cystic fibrosis is a severe hereditary disease of the lung, for which there is currently no cure. The underlying cause of the disease is...
Advances in the Prevention and Treatment of MRSA in Patients with Cystic Fibrosis
Active research and special expertise at Cleveland Clinic’s Adult CF Center Methicillin-resistant Staphylococcus aureus (MRSA) increases...
Galapagos Initiates Phase 1 Trial to Evaluate CF Corrector GLP3221 in Healthy Volunteers
Galapagos has initiated a Phase 1 clinical trial in healthy volunteers to evaluate a new C2 corrector, called GLPG3221, developed for the...